No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs574334565 |
chr9:117221276-117221277 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs4978589 |
chr9:117221359-117221360 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs148132345 |
chr9:117221397-117221398 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs7041286 |
chr9:117221415-117221416 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
5 |
rs189371722 |
chr9:117221437-117221438 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs565206783 |
chr9:117221508-117221509 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs182369899 |
chr9:117221512-117221513 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs550828510 |
chr9:117221524-117221525 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs199984459 |
chr9:117221583-117221584 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs386415965 |
chr9:117221584-117221585 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs386415966 |
chr9:117221593-117221594 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs397799474 |
chr9:117221594-117221595 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs566585703 |
chr9:117221618-117221619 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs567849579 |
chr9:117221639-117221640 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs530364282 |
chr9:117221680-117221681 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs547267305 |
chr9:117221689-117221690 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs184762718 |
chr9:117221702-117221703 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs538219340 |
chr9:117221717-117221718 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs558543057 |
chr9:117221724-117221725 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs189486595 |
chr9:117221730-117221731 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs11447125 |
chr9:117221741-117221742 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs397767439 |
chr9:117221749-117221750 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs537939691 |
chr9:117221773-117221774 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs558527336 |
chr9:117221817-117221818 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs577198849 |
chr9:117221821-117221822 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs144112093 |
chr9:117221828-117221829 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs7868739 |
chr9:117221864-117221865 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
28 |
rs7868975 |
chr9:117221897-117221898 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
29 |
rs553615965 |
chr9:117221953-117221954 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs577089993 |
chr9:117221966-117221967 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs545808664 |
chr9:117221987-117221988 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs565267332 |
chr9:117222016-117222017 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs181487527 |
chr9:117222032-117222033 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs564982556 |
chr9:117222041-117222042 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs186218958 |
chr9:117222043-117222044 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs561370736 |
chr9:117222091-117222092 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs530274491 |
chr9:117222126-117222127 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs547228350 |
chr9:117222150-117222151 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs146899703 |
chr9:117222184-117222185 |
Weak transcription Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs532816729 |
chr9:117222207-117222208 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs4978590 |
chr9:117222230-117222231 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
42 |
rs367990827 |
chr9:117222263-117222264 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs10759707 |
chr9:117222287-117222288 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
44 |
rs537448985 |
chr9:117222313-117222314 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs554206462 |
chr9:117222371-117222372 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs76515312 |
chr9:117222388-117222389 |
Enhancers Active TSS Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs533711249 |
chr9:117222450-117222451 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs553530138 |
chr9:117222463-117222464 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs191326414 |
chr9:117222468-117222469 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs181442937 |
chr9:117222514-117222515 |
Enhancers Weak transcription Bivalent Enhancer Strong transcription
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|